MaxCyte (MXCT, $4.64) was one of the top gainers this week, climbing +2 to $4.64 per share. A.I.dvisor analyzed 460 stocks in the Medical Specialties Industry over the last week and discovered that of them (6) trended up while of them (3) trended down.